![Immunology / Rheumatoid arthritis / Tofacitinib / Disease-modifying antirheumatic drug / Adalimumab / Leflunomide / Etanercept / Infliximab / Golimumab / Immunosuppressants / Pharmacology / Medicine Immunology / Rheumatoid arthritis / Tofacitinib / Disease-modifying antirheumatic drug / Adalimumab / Leflunomide / Etanercept / Infliximab / Golimumab / Immunosuppressants / Pharmacology / Medicine](https://www.pdfsearch.io/img/d0fb44fc0cfd58c072c14c39af31dd5d.jpg) Date: 2014-08-12 13:02:45Immunology Rheumatoid arthritis Tofacitinib Disease-modifying antirheumatic drug Adalimumab Leflunomide Etanercept Infliximab Golimumab Immunosuppressants Pharmacology Medicine | | Xeljanz® (tofacitinib tablets – Pfizer) To Initiate a Coverage Review, Call[removed]OVERVIEW Xeljanz is an inhibitor of the Janus kinases (JAK) pathways approved for the treatment of adults with moderately to s
Document is deleted from original location. Use the Download Button below to download from the Web Archive.Download Document from Web Archive File Size: 111,95 KB
|